Physician profile
Tracee Trapanese
NPI 1366576423
$6,330.42
in general payments reported to CMS, 2019-2025
39 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,144 · 2022: $1,213 · 2023: $1,473 · 2024: $1,280 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,525 · Travel and Lodging: $281 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,525.32 |
| Travel and Lodging | $281.37 |
| Education | $167.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,052.47 | 2021-2025 | Erleada, Akeega |
| Axonics, INC. | $568.10 | 2022-2023 | Axonics |
| Astellas Pharma US INC | $489.33 | 2021-2025 | Myrbetriq, Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $368.83 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $353.30 | 2021-2025 | Myrisk, Prolaris |
| Abbvie INC. | $348.53 | 2021-2025 | |
| Antares Pharma, INC. | $294.92 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $285.83 | 2021-2025 | |
| Telix Pharmaceuticals | $199.79 | 2022-2025 | Illuccix |
| Tolmar, INC. | $194.18 | 2023-2025 | Jatenzo, Eligard |
| Tolmar Pharmaceuticals, INC. | $188.55 | 2021-2022 | |
| Urovant Sciences INC | $174.37 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $157.16 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $150.96 | 2023-2025 | |
| Boston Scientific Corporation | $150.25 | 2021-2025 | Axonics |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $143.99 | 2021-2025 | Speedicath |
| Verity Pharmaceuticals INC. | $140.26 | 2022-2025 | Trelstar, Tlando |
| Sumitomo Pharma America, INC. | $119.27 | 2023-2025 | Gemtesa |
| Mission Pharmacal Company | $103.32 | 2021-2024 | Uribel, Uribel Tabs |
| Becton, Dickinson and Company | $82.28 | 2024-2025 | Bard Urinary Drainage Bag |
| Acerus Pharmaceuticals Corporation | $72.13 | 2021-2022 | |
| Blue Earth Diagnostics | $66.89 | 2021-2024 | |
| Endo USA, INC. | $65.03 | 2024-2025 | Xiaflex |
| Myovant Sciences INC. | $64.44 | 2021-2022 | |
| Convatec INC. | $58.04 | 2022-2024 | |
| Immunitybio, INC. | $52.50 | 2024-2025 | |
| Olympus America INC. | $51.05 | 2021-2025 | Itind System, Bovie |
| Dendreon Pharmaceuticals LLC | $42.11 | 2022-2025 | Provenge |
| Halozyme INC | $41.18 | 2023 | |
| Merck Sharp & Dohme LLC | $41.06 | 2022-2023 | Lynparza, Keytruda |
| Accord Healthcare, INC. | $38.26 | 2023 | |
| Clarus Therapeutics INC. | $36.50 | 2021 | |
| Teleflex LLC | $26.23 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $23.65 | 2022 | |
| Medtronic, INC. | $20.11 | 2024 | Interstim |
| Ethicon US, LLC | $19.18 | 2024 | Stratafix, Enseal X1, Ethicon |
| Menarini Silicon Biosystems, INC. | $17.20 | 2023 | Cellsearch |
| Laborie Medical Technologies Corp. | $16.36 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracee Trapanese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.